Innoray

Innoray Medical, founded in 2022 and headquartered in the Lingang Special Area of Shanghai, was awarded the qualification of the first batch of technology-based small and medium-sized enterprises in 2025. The company focuses on providing medical devices and management solutions covering the entire process of prevention, screening, diagnosis, testing, and treatment for bone metabolism-related diseases. As a pioneer in the industry, Innoray Medical has successfully collaborated with several well-known tertiary hospitals across China and won the bid for the national key science and technology project "Research on the Prevention and Treatment of Cancer, Cardiovascular and Cerebrovascular Diseases, Respiratory Diseases, and Metabolic Diseases," committing to promoting the clinical transformation and practical application of related innovative technologies.